MedTrace Logo

Low Dose Spinal Bupivacaine for Total Knee Replacement and Recovery Room Wait Time

NCT00537472 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 140

Last updated 2009-04-17

No results posted yet for this study

Summary

This study plans to investigate whether a reduced dose of bupivacaine (a local anesthetic numbing drug) injected into the spinal space for a total knee replacement will result in a shorter time to discharge from the recovery room while maintaining adequate surgical anesthesia.

Conditions

  • Spinal Anesthesia
  • Total Knee Arthroplasty

Interventions

DRUG

Low dose bupivicaine in spinal anesthetic

Bupivacaine 9 mg intrathecal single shot injection at start of surgery

DRUG

Standard dose bupivacaine in spinal anesthetic

Bupivacaine 13 mg intrathecal single shot injection at start of surgery

Sponsors & Collaborators

  • Queen's University

    lead OTHER

Principal Investigators

  • Melanie Jaeger, MD, FRCPSC · Staff anesthesiologist at Kingston General Hospital

  • Dale Engen, MD, FRCPSC · Staff anesthesiologist at Kingston General Hospital

  • Devin Sydor, MD · Anesthesiology resident at Kingston General Hospital/Queen's University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-12-31
Completion
2008-12-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00537472 on ClinicalTrials.gov